Parkinson's Disease Clinical Trial
Official title:
Power Training to Reduce Falls in Parkinson's Disease
NCT number | NCT02476266 |
Other study ID # | 3992 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2015 |
Est. completion date | September 2016 |
Verified date | March 2020 |
Source | Sun Life Financial Movement Disorders Research and Rehabilitation Centre |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Parkinson's disease (PD) is a chronic neurodegenerative disorder that is characterized by a multitude of symptoms. Impairments in balance, muscle deficits and increased risk of falls are commonly experienced in PD.The purpose of this study is to investigate the effects of two different resistance training programs on improving balance and muscular strength to thereby reduce the risk of falls in those with PD. This study will randomize individuals to one of two groups, a power training group, or a strength training group. Both interventional groups will participate in 12 weeks of resistance training, two times per week for an hour each exercise session.
Status | Completed |
Enrollment | 53 |
Est. completion date | September 2016 |
Est. primary completion date | June 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Diagnosed with idiopathic PD by a Neurologist - Able to stand two minutes, unassisted - Able to understand English instructions - Signed Physical Activity Readiness Medical Examination (PARmed-X) by physician Exclusion Criteria: - a neurological disease other than PD - peripheral neuropathy - physical impairments that would prevent participation in the muscular strength testing - uncontrolled hypertension |
Country | Name | City | State |
---|---|---|---|
Canada | Sunlife Financial Movement Disorders Research and Rehabilitation Centre- Wilfrid Laurier University | Waterloo | Ontario |
Lead Sponsor | Collaborator |
---|---|
Sun Life Financial Movement Disorders Research and Rehabilitation Centre |
Canada,
Glendinning DS, Enoka RM. Motor unit behavior in Parkinson's disease. Phys Ther. 1994 Jan;74(1):61-70. Review. — View Citation
Newton RU, Murphy AJ, Humphries BJ, Wilson GJ, Kraemer WJ, Häkkinen K. Influence of load and stretch shortening cycle on the kinematics, kinetics and muscle activation that occurs during explosive upper-body movements. Eur J Appl Physiol Occup Physiol. 1997;75(4):333-42. — View Citation
Stolze H, Klebe S, Baecker C, Zechlin C, Friege L, Pohle S, Deuschl G. Prevalence of gait disorders in hospitalized neurological patients. Mov Disord. 2005 Jan;20(1):89-94. — View Citation
Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M, Parashos SA. Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes. Mov Disord. 2005 Apr;20(4):410-5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Parkinson's disease Quality of Life Questionnaire (PDQ-39) | It is one of the most widely used questionnaires to assess the quality of life of individuals with Parkinson's disease. For the purposes of this study it is imperative to identify if those that are at a higher risk of falling have a lower quality of life rating, as has been reported in previous studies. It is important to observe if the proposed measure that is to be validated is correlated with quality of life ratings. | Change in score from baseline to 12 weeks | |
Other | CHAMPS Questionnaire | This questionnaire is able to quantify the amount of physical activity that older adults complete. This questionnaire is being used to control for varying activity levels, as it is proposed that those that have lower levels of physical activity are at a greater risk of falls. It is a self-administered questionnaire that takes approximately 10 to 15 minutes to complete. As well this questionnaire is important to administer, as participants will be asked to come in over a period of time, it is necessary to control and account for changes in physical activity levels that might influence the other outcome measures in this study. | Changes in score from baseline to 12 weeks | |
Other | CHAMPS Questionnaire | This questionnaire is able to quantify the amount of physical activity that older adults complete. This questionnaire is being used to control for varying activity levels, as it is proposed that those that have lower levels of physical activity are at a greater risk of falls. It is a self-administered questionnaire that takes approximately 10 to 15 minutes to complete. As well this questionnaire is important to administer, as participants will be asked to come in over a period of time, it is necessary to control and account for changes in physical activity levels that might influence the other outcome measures in this study. | Changes in score from 12 weeks three month wash out | |
Other | CHAMPS Questionnaire | This questionnaire is able to quantify the amount of physical activity that older adults complete. This questionnaire is being used to control for varying activity levels, as it is proposed that those that have lower levels of physical activity are at a greater risk of falls. It is a self-administered questionnaire that takes approximately 10 to 15 minutes to complete. As well this questionnaire is important to administer, as participants will be asked to come in over a period of time, it is necessary to control and account for changes in physical activity levels that might influence the other outcome measures in this study. | Changes in score from 12 weeks six month wash out | |
Primary | Lean-and-Release Perturbation Technique. | This measure will require participants to be in a forward static lean at a maximum lean angle of 20 degrees from the vertical. This measure will induce a fall like situation where participants will be required to respond to this "perturbation" as they would in a slip or a trip scenario in real life. Muscle activity will be collected through surface electromyography (sEMG) to measure muscular responses associated with the perturbation. Measurement of postural adjustments will be made on an electronic carpet. sEMG and postural adjustments will demonstrate participants' onset of muscular activation time, latency to stepping, movement speed, and stepping characteristics. | Change in muscle activity, compensatory postural responses from baseline to 12 weeks. | |
Primary | Lean-and-Release Perturbation Technique. | Change in muscle activity, compensatory postural responses from 12 weeks to three month wash out | ||
Primary | Lean-and-Release Perturbation Technique. | Change in muscle activity, compensatory postural responses from 12 weeks to six month wash out | ||
Secondary | Unified Parkinson's Disease Rating Scale Motor Subsection (UPDRS III) | Motor symptom severity as assessed by a movement disorders specialist | Change in motor severity from baseline to 12 weeks | |
Secondary | Unified Parkinson's Disease Rating Scale Motor Subsection (UPDRS III) | Change in motor severity from 12 weeks to three month wash out | ||
Secondary | Unified Parkinson's Disease Rating Scale Motor Subsection (UPDRS III) | Change in motor severity from 12 weeks to six month wash out | ||
Secondary | Gait Measurement | This measures spatiotemporal gait parameters of individuals. This will allow measurement of key predictors of fall risk in PD, including step length, step time, step width, velocity, double support time, double support time percentage, step time variability, and step length variability. Participants will also perform a secondary digit-monitoring task while walking in the same well-lit open room. Participants will walk while simultaneously listening to an audio track of random numbers greater than zero and less than 10. For each trial that included this task, the participants are assigned two specific digits and will be instructed to silently count (without the use of manual aid) the number of times those two digits were announced by the audio track, separately. At the end of the trial the participants will be asked to inform the tester of the number of times they heard each digit. | Changes in gait measures from baseline to 12 weeks | |
Secondary | Gait Measurement | This measures spatiotemporal gait parameters of individuals. This will allow measurement of key predictors of fall risk in PD, including step length, step time, step width, velocity, double support time, double support time percentage, step time variability, and step length variability. Participants will also perform a secondary digit-monitoring task while walking in the same well-lit open room. Participants will walk while simultaneously listening to an audio track of random numbers greater than zero and less than 10. For each trial that included this task, the participants are assigned two specific digits and will be instructed to silently count (without the use of manual aid) the number of times those two digits were announced by the audio track, separately. At the end of the trial the participants will be asked to inform the tester of the number of times they heard each digit. | Changes in gait measures from 12 weeks to three month wash out | |
Secondary | Gait Measurement | This measures spatiotemporal gait parameters of individuals. This will allow measurement of key predictors of fall risk in PD, including step length, step time, step width, velocity, double support time, double support time percentage, step time variability, and step length variability. Participants will also perform a secondary digit-monitoring task while walking in the same well-lit open room. Participants will walk while simultaneously listening to an audio track of random numbers greater than zero and less than 10. For each trial that included this task, the participants are assigned two specific digits and will be instructed to silently count (without the use of manual aid) the number of times those two digits were announced by the audio track, separately. At the end of the trial the participants will be asked to inform the tester of the number of times they heard each digit. | Changes in gait measures from 12 weeks to six month wash out | |
Secondary | Balance Measurement | The Biodex Balance System™ SD will be used to assess balance outcomes. Specifically participants will be asked to complete two static balance tasks: i) eyes open- participants will be required to stand quietly for thirty seconds looking straight ahead and ii) eyes closed- participants will be required to stand quietly for thirty seconds with their eyes closed. Centre of pressure excursion will be measured in the anterior-posterior and medial-lateral directions to give an indication of participants overall postural stability. | Changes in postural stability measures from baseline to 12 weeks | |
Secondary | Balance Measurement | The Biodex Balance System™ SD will be used to assess balance outcomes. Specifically participants will be asked to complete two static balance tasks: i) eyes open- participants will be required to stand quietly for thirty seconds looking straight ahead and ii) eyes closed- participants will be required to stand quietly for thirty seconds with their eyes closed. Centre of pressure excursion will be measured in the anterior-posterior and medial-lateral directions to give an indication of participants overall postural stability. | Changes in postural stability measures from 12 weeks to three month wash out | |
Secondary | Balance Measurement | The Biodex Balance System™ SD will be used to assess balance outcomes. Specifically participants will be asked to complete two static balance tasks: i) eyes open- participants will be required to stand quietly for thirty seconds looking straight ahead and ii) eyes closed- participants will be required to stand quietly for thirty seconds with their eyes closed. Centre of pressure excursion will be measured in the anterior-posterior and medial-lateral directions to give an indication of participants overall postural stability. | Changes in postural stability measures from 12 weeks to six month wash out | |
Secondary | Muscular Strength and Power Assessment | Technogym Selection Leg Press used to assess muscular strength and power. Participants will be completing a submaximal muscular strength protocol (multiple repetition maximum), which can be used to predict a one repetition maximum (1-RM). | Changes in muscle strength measures from baseline to 12 weeks | |
Secondary | Muscular Strength and Power Assessment | Technogym Selection Leg Press used to assess muscular strength and power. Participants will be completing a submaximal muscular strength protocol (multiple repetition maximum), which can be used to predict a one repetition maximum (1-RM). | Changes in muscle strength measures from 12 weeks to three month wash out | |
Secondary | Muscular Strength and Power Assessment | Technogym Selection Leg Press used to assess muscular strength and power. Participants will be completing a submaximal muscular strength protocol (multiple repetition maximum), which can be used to predict a one repetition maximum (1-RM). | Changes in muscle strength measures from 12 weeks to six month wash out | |
Secondary | Timed Up and Go (TUG) | A timed up and go test (TUG test) will be administered as an assessment of function. Briefly, participants will be asked to begin the test by sitting in a chair, then to get up out of the chair without use of their hands and walk three metres then turn around and walk back to the chair and sit in it. Gait characteristics will be measured (step time, step length, step variability, velocity, time spent in double support. This test will occur three times. | Changes in time and gait measures from baseline to 12 weeks | |
Secondary | Timed Up and Go (TUG) | A timed up and go test (TUG test) will be administered as an assessment of function. Briefly, participants will be asked to begin the test by sitting in a chair, then to get up out of the chair without use of their hands and walk three metres then turn around and walk back to the chair and sit in it. Gait characteristics will be measured (step time, step length, step variability, velocity, time spent in double support. This test will occur three times. | Changes in time and gait measures from 12 weeks to three month wash out | |
Secondary | Timed Up and Go (TUG) | A timed up and go test (TUG test) will be administered as an assessment of function. Briefly, participants will be asked to begin the test by sitting in a chair, then to get up out of the chair without use of their hands and walk three metres then turn around and walk back to the chair and sit in it. Gait characteristics will be measured (step time, step length, step variability, velocity, time spent in double support. This test will occur three times. | Changes in time and gait measures from 12 weeks to six month wash out | |
Secondary | Thirty Second Sit to Stand | A thirty second sit to stand test will also be used as it is a functional measure of lower limb muscle strength. Participants will begin the test by sitting in a chair that is placed against a wall for safety. They will then be asked to go from a sitting position to a standing position as many times as possible in a thirty second time frame. | Change in number of sit to stands completed from baseline to 12 weeks | |
Secondary | Thirty Second Sit to Stand | A thirty second sit to stand test will also be used as it is a functional measure of lower limb muscle strength. Participants will begin the test by sitting in a chair that is placed against a wall for safety. They will then be asked to go from a sitting position to a standing position as many times as possible in a thirty second time frame. | Change in number of sit to stands completed from 12 weeks to three month wash out | |
Secondary | Thirty Second Sit to Stand | A thirty second sit to stand test will also be used as it is a functional measure of lower limb muscle strength. Participants will begin the test by sitting in a chair that is placed against a wall for safety. They will then be asked to go from a sitting position to a standing position as many times as possible in a thirty second time frame. | Change in number of sit to stands completed from 12 weeks to six month wash out |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Completed |
NCT02874274 -
Vaccination Uptake (VAX) in PD
|
N/A |